Ropinirole-dextran sulfate nanoplex for nasal administration against Parkinson's disease: in silico molecular modeling and in vitro-ex vivo evaluation.
about
Ropinirole-dextran sulfate nanoplex for nasal administration against Parkinson's disease: in silico molecular modeling and in vitro-ex vivo evaluation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@en
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@nl
type
label
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@en
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@nl
prefLabel
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@en
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@nl
P2860
P1476
Ropinirole-dextran sulfate nan ...... d in vitro-ex vivo evaluation.
@en
P2093
Chandrakantsing Vijaysing Pardeshi
Veena Shailendra Belgamwar
P2860
P304
P356
10.3109/21691401.2016.1167703
P577
2016-04-11T00:00:00Z